These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9650146)

  • 1. Accountability in public short-term adult AOD residential treatment. Fontainebleau Treatment Center.
    Hyde A; Vollmerhausen S
    J Subst Abuse Treat; 1998; 15(4):367-75. PubMed ID: 9650146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of depression treatment for co-occurring disorders: a clinical trial.
    Watkins KE; Cuellar AE; Hepner KA; Hunter SB; Paddock SM; Ewing BA; de la Cruz E
    J Subst Abuse Treat; 2014 Feb; 46(2):128-33. PubMed ID: 24094613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Service-level costing of drug abuse treatment.
    Anderson DW; Bowland BJ; Cartwright WS; Bassin G
    J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review.
    de Andrade D; Elphinston RA; Quinn C; Allan J; Hides L
    Drug Alcohol Depend; 2019 Aug; 201():227-235. PubMed ID: 31254749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of substance abuse during pregnancy.
    Lester BM; Twomey JE
    Womens Health (Lond); 2008 Jan; 4():67-77. PubMed ID: 19072452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating managed mental health programs.
    Whitted GS; Kunnes R
    AAPPO J; 1993; 3(2):27-30. PubMed ID: 10171662
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost of residential addiction treatment in public housing.
    Alexandre PK; Roebuck MC; French MT; Barry M
    J Subst Abuse Treat; 2003 Jun; 24(4):285-90. PubMed ID: 12867201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental stress and child behavioral outcomes following substance abuse residential treatment. Follow-up at 6 and 12 months.
    Killeen T; Brady KT
    J Subst Abuse Treat; 2000 Jul; 19(1):23-9. PubMed ID: 10867297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the feasibility of performance measures for alcohol and other drugs.
    Garnick DW; Lee MT; Chalk M; Gastfriend D; Horgan CM; McCorry F; McLellan AT; Merrick EL
    J Subst Abuse Treat; 2002 Dec; 23(4):375-85. PubMed ID: 12495800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unit cost of counseling and patients length of stay in a residential drug treatment setting.
    Alemi F; Haack M; Holifield L; Claudio Y; Haqqi K
    J Ment Health Policy Econ; 2002 Sep; 5(3):103-7. PubMed ID: 12728196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the accountability of California's public substance abuse treatment system through the implementation of performance models.
    Rawson RA; Gonzales R; Crèvecoeur-MacPhail D; Urada D; Brecht ML; Chalk M; Kemp J; Cunningham M
    J Psychoactive Drugs; 2010 Sep; Suppl 6():211-4. PubMed ID: 21138197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental health and substance abuse services in the era of health care reform.
    Boyer JF
    J Ambul Care Manage; 1993 Oct; 16(4):50-9. PubMed ID: 10171525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking and Tobacco-Free Policies in Women's Residential Substance Use Disorder Treatment Facilities: A Community-Engaged Approach.
    Fallin-Bennett A; Parker KA; Miller A; Ashford K; Hahn EJ
    Nicotine Tob Res; 2018 Sep; 20(11):1386-1392. PubMed ID: 29059449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scouting in adolescent treatment programs: building a foundation.
    Austin BD
    J Psychosoc Nurs Ment Health Serv; 1990 Jul; 28(7):24-5. PubMed ID: 2376849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.